Special notice
Notice of Intent to Sole Source
FDA-1284766
Department of Health and Human Services, Department of Health and Human Services. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
June 16, 2025 at 3:00 PM EDT
Closed 458 days ago. Posted June 5, 2025. Scheduled to archive June 17, 2025.
Description
As published on SAM.gov.
The objective of the contract is to obtain Human Induced Pluripotent Stem Cell-Derived Cells. These cells will provide the FDA with the required material to support MPS studies. The cells will enable scientific capabilities consistent with the mission of the Center for Drug Evaluation and Research (CDER).
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 5, 2025
Special notice
Due June 16, 2025 at 3:00 PM EDT. SAM.gov, notice 2d472891df0849d8a95445c03c94ee7d
Points of contact
- Rodney D. Aytchrodney.aytch@fda.hhs.gov2404027514